Operation Warp Speed, but for Everything Government Does
@foxnews.com3 years ago
Pfizer seeks emergency authorization for COVID-19 booster in children ages 5 to 11
@forbes.com4 years ago
In A Euphoric Announcement, The FDA Approves Pfizer-BioNTech Vaccine
@forbes.com4 years ago
Doctors Tweet About Vaccinating Their Children With Covid-19 Vaccines Imminently Available For 12 To 15 Year Olds
@politico.com4 years ago
U.S. buys another 100M doses of Pfizer-BioNTech coronavirus vaccine
@WSJ4 years ago
The first Pfizer-BioNTech vaccine vials are set to arrive Monday morning and some U.S. hospitals plan to start administering Covid-19 shots within hours on.wsj.com
@forbes.com4 years ago
The U.S. Has Ordered Enough Of Pfizer’s Covid-19 Vaccine For 50 Million People—But That’s All
@abcnews.go.com4 years ago
Pfizer, BioNTech to seek FDA authorization Friday for COVID-19 vaccine
@reuters.com5 years ago
Pfizer, BioNTech to co-develop potential coronavirus vaccine
@forbes.com2 years ago
Pfizer Covid-19 Bivalent Vaccine And Stroke Risk: What You Need To Know
@dailywire.com3 years ago
FDA Approves Second Booster For Older Adults, Some Immunocompromised People
@WSJ4 years ago
The U.S. bought 200 million additional Covid-19 vaccine doses from Pfizer Inc. and partner BioNTech SE at about $24 a shot, above the $19.50 price of previous deals on.wsj.com
@WSJ4 years ago
Pfizer and BioNTech plan to soon test a freeze-dried version of its Covid-19 vaccine, which if proven to work safely could ease storage and handling of the shots in rural U.S. areas and low-income countries on.wsj.com
@forbes.com4 years ago
Pfizer-BioNTech And Moderna Covid-19 Vaccines: Here Are 5 Differences
@WSJ4 years ago
The U.S. authorized its first Covid-19 vaccine, a landmark in the fight against the pandemic. The Pfizer-BioNTech shots will be available in days. on.wsj.com
@WSJ4 years ago
The first batches of the Pfizer-BioNTech coronavirus vaccine have been delivered to U.K. hospitals, as the U.S. says it could authorize the vaccine within days #WSJWhatsNowt.co
@WSJ5 years ago
The U.S. will pay $1.95 billion to Pfizer and BioNTech to secure hundreds of millions of doses of a Covid-19 vaccine that Americans would receive for free on.wsj.com
@WSJ3 years ago
Pfizer and BioNTech began tinkering with their Covid-19 vaccine before new Omicron strains spread in the U.S. The preparations are a big reason the reformulated boosters are rolling out now. on.wsj.com
@WSJ3 years ago
Pfizer and BioNTech have asked U.S. regulators to fully approve their Covid-19 vaccine for 12- to 15-year-olds on.wsj.com
@snopes.com4 years ago
Moderna Says Its COVID-19 Shot Works in Kids As Young As 12
@forbes.com4 years ago
Pfizer-BioNTech Vaccine Appears Resistant To New Covid Variant, Study Finds, As U.S. Records Deadliest Day
@jezebel.com4 years ago
The Vaccine Needs to Be Cold As Balls
@snopes.com4 years ago
Pfizer’s COVID-19 Vaccine Data Hacked during Cyberattack
@forbes.com4 years ago
Here’s Why The U.K. Beat The U.S. To Approve A Covid-19 Vaccine For Emergency Use
@dailywire.com5 years ago
BREAKING: Trump Admin Secures Up To 600M Coronavirus Vaccine Doses With Pfizer, Free To Americans
@forbes.com3 years ago
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
@forbes.com3 years ago
U.S. Purchases Additional 50 Million Pediatric Doses Of Covid-19 Vaccine, Pfizer Says
@dailywire.com4 years ago
FDA Approves Pfizer COVID-19 Vaccine For Adolescents Ages 12-15
@axios.com4 years ago
Over 1 million people in U.S. have received the COVID-19 vaccine
@WSJ4 years ago
More U.S. hospitals on Tuesday began receiving shipments of the Covid-19 vaccine developed by Pfizer and BioNTech, as distributors worked to get millions of doses to 636 sites across the country by Wednesday on.wsj.com
@WSJ4 years ago
The FDA is set to release analyses of the Pfizer-BioNTech vaccine, the first Covid-19 shot being considered for U.S. distribution on.wsj.com
@WSJ4 years ago
Pfizer and BioNTech plan to ask health regulators soon to authorize their Covid-19 vaccine, after more data show it is working safely. If the FDA gives a thumbs-up, the shot would be the first to go into use in the U.S. Here’s what we know and don’t know. on.wsj.com
@WSJ5 years ago
Researchers began human testing in the U.S. of a potential coronavirus vaccine developed by Pfizer and German partner BioNTech on.wsj.com
